We believe our software, ClinPay FLS, will revolutionize the way financials behind clinical trials are handled. Sites can get paid faster, and sponsors can process payments easier. I want to let the attendees of MAGI West know more about it.
Past News ReleasesRSS
Raleigh, NC (PRWEB) October 19, 2012
Tim Immel, CEO of Clinverse, a global technology company delivering highly-secure, cloud-based, financial management and payment solutions to the clinical trials industry, will be presenting at MAGI West. The conference will be held Oct. 21-24 at the Hilton San Diego Bayside Hotel.
Immel will join with Medidata Solutions to co-host “Technology Showcase: Automating the Payment Process” on Tuesday, October 23 at 2:45 pm. The program will focus on how sites, sponsors, CROs and clinical trial managers can use technology to enhance site relations and expedite the payment process.
MAGI West offers 90 workshops centered on sponsor and site operations, contracts, budgeting, billing, regulatory compliance, quality and other clinical research-related topics. Over 500 attendees are expected.
Immel is uniquely familiar with the financial procedures that plague the clinical trial process; his company’s ClinPay Financial Lifecycle System (FLS)™ software is the only Medidata Solutions-recognized solution in the industry.
“We are very excited to be attending MAGI West with our friends and peers,” Immel said. “We believe our software, ClinPay FLS, will revolutionize the way financials behind clinical trials are handled. Sites can get paid faster, and sponsors can process payments easier. The entire process is going to be improved upon; automation delivers countless benefits. And I want to let the attendees of MAGI West know more about it.”
About Clinverse (http://www.clinverse.com)
Headquartered in Raleigh, N.C., Clinverse delivers solutions through the only collaborative eClinical eCommerce network now in use by leading biopharma and other customers. ClinPay FLS™, the company’s flagship accounting cloud-based software, automates the financial management of trials—allowing sponsors, CROs and investigators to focus on clinical operations. Its patent-pending, proprietary technology is fully customizable and supports payments in 140 currencies.